English French
RespIn 11 Bronchial Clearance System
A totally new innovative approach to the 30 year old concept of HFCWO/HFCC therapy making maximum use of modern technology and material.

What People are Saying

Piper emphatically loves the Respin Vest! She described it as a ‘massage’ compared to the painful pounding of her other machine. When we took the demo machine away from her she was very upset and cried to keep it. This is heart breaking as a parent and I hope to get her back to using the Respin Vest as soon as possible!
T.S.
T.S.
Daughter (8 years old) has CF
I found out about the RespIn 11 at NACFC. We went with the RespIn 11 because they were able to custom fit my patient. The patient is a 26F with advanced CF, she was non-adherent with her conventional vest because of breast sensitivity. After 8 months of use her pulmonary function tests demonstrated stability. Thanks for all your help.
Jeff Tarnow
Jeff Tarnow
R.T.
I am really pleased with my RespIn 11 in fact I couldn't do without it. I use it twice daily and on difficult days a third session.
P.W.
P.W.
Bronchiectasis/COPD Sufferer

RespIn 11 Bronchial Clearance System

RespIn 11 Bronchial Airway Clearance System is a "Focused Pulse" High Frequency Chest Wall Oscillation (HFCWO) device that maximizes the use of modern technologies and materials to produce a more comfortable, flexible and effective therapy delivery system.

Through the use of modern technologies and materials, these systems produce a high quality therapy without pain or irritation associated with other "Vest Therapy Systems".  Respin 11 uses a patented system of valves, electronic control and targeted pressure pistons to deliver pulsations directly to targeted areas of the patient's thorax - exactly where they are needed.

RespInnovation SAS has conceptualized, designed and realized its RespIn 11 Bronchial Airway Clearance System as a 2nd generation ‘focused pulse’ High Frequency Chest Wall Oscillation (HFCWO) device that maximizes the use of modern technologies and materials to produce a more comfortable, flexible and effective therapy delivery system.  The RespIn 11 uses an innovative patented system of ‘focused pulse’ technology incorporating a system of proprietary valves, pressure pistons and electronic controls which deliver therapeutic pulsations directly to targeted areas of the patient’s thorax - exactly where most required and most beneficial in the treating clinician’s view.

RespIn 11 benefits from a totally new innovative approach to the 30 year old concept of High Frequency Chest Wall Oscillation/Chest Compression therapy and makes maximum use of modern technologies and materials to:

• Delivers therapeutic ‘focused pulse’ therapy direct to selected parts of the patient thorax creating a more profound and efficient resonance in the bronchial airways which is delivered in a comfortable ‘massage like’ therapy.

• Flexibility of RespIn 11’s ‘focused pulse’ technology also gives treating clinicians greatly increased control and flexibility of therapy to best meet the needs of each individual patient and clinical condition.

• Very low background pressure - The RespIn 11 patented system of focused pulsations cycle from empty to full up to 20 times per second yet operates at a very low background pressure which is very beneficial to patients on both a comfort level during treatment and also therapeutic level with greatly increased efficiency in dislodging mucus and assisting its movement for
expectoration.

• No negative physiological side effects - as a beneficial side effect of its low operating pressure of RespIn 11’s ‘focused pulse’ technology, it has no negative side effects to the patient’s physiological parameters, e.g. blood pressure and heart rate, and the RespIn 11 can therefore be safely used with a much wider range of patients and clinical conditions than existing Chest Compression devices.

Download RespIn 11 Info Pack

 

 

REGISTER YOUR DEVICE

In order to validate your warranty you need to register your RespIn Unit with RespInnovation.

Click to Register


 

VIRTUOUS CIRCLE

 

Read More


 

CLINICAL TRIAL

Click below to access our latest Clinical Trial showing the effectiveness of the RespIn 11 Bronchial Clearance System.

Clinical Trial


 

RespIn News

CIU - Health Association France Award

16th December 2015: RespInnovation receives an award in the 'Health' category.

Prize awarded - Free display of our RespIn 11 for 6 months within the simulation apartment dedicated to home health and independence for simulation of activities of daily living. Apartment on the Living Lab Health, 27 rue du Pr Delvalle, Nice aims to receive inhabitants of the territory and professionals in the field of health and welfare.

1st Trophy Living Lab Innovation in Health, Independence, Well-being, launched by the CIU-Health Association FRANCE:

  • Enable companies to exhibit their innovative solutions for home health and autonomy within the Living Lab Health.
  • To explain to people in loss of autonomy (elderly, people with physical, mental or chronic illness ...), their caregivers and healthcare professionals of new technologies that make life easier at home through a familiar and domestic environment.

 

                 http://www.ciusante.org/living-lab-sante-paillon2020/trophees-du-living-lab-paillon2020/

 

'focused pulse' Technology

Clinical and scientific studies have shown that ‘focused pulse’ pressure piston technology used in the RespIn 11 creates 4 – 6 times greater oscillation in the most important area of the lungs (from the 5th to 15th generation of the bronchial tree) where most mucus accumulates, more effectively dislodging secretions and soliciting coughing.
The RespIn 11 creates this increased amplitude of bronchial oscillation while only transferring 1/10th of the energy to the patients thorax compared to existing HFCWO devices making the RespIn 11 far easier to tolerate, increasing adherence thus promoting better long term results.

Low Background Pressure

The RespIn 11 patented system of focused pulsations operates at a very low background pressure which is very beneficial to patients on both a comfort level during treatment and also therapeutic level with greatly increased efficiency in dislodging mucus and assisting its movement for expectoration.
This greatly reduced background pressure enables clinicians to successfully treat patients currently unable to tolerate existing HFCWO/Chest Compression devices for example neuro-muscular, long term care, the elderly, fragile patients, etc.

Wider Clinical Applications

Improved safety and a wider range of clinical applications are possible because the RespIn 11 has been shown to cause no important negative changes to various patient physiological parameters, i.e. making Blood Pressure, Heart Rate rise as existing HFCWO/Chest Compression devices can do.
Our Head to Head Pre-Clinical Trial FDA Safety Study data verifies that both these figures did not increase during RespIn 11 therapy sessions of 15 or 20 minutes yet a significant percentage of participants did show important Blood Pressure increases using the comparative HFCWO device.